// App-Quantinova.ai

OC 57.5 : Downregulation of Thrombomodulin-Thrombin-Activated Protein C pathway as a mechanism for SARS-CoV-2 induced endotheliopathy and microvascular thrombosis

Researchers

Presenter

  • S. Agarwal

Principal Investigators

  • N/A

Medical Centers

  • Pediatrics, Texas Childrens Hospital, Baylor College of Medicine, Houston, Texas, United States

  • Pediatrics, Texas Childrens Hospital, Baylor College of Medicine, Houston, Texas, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • Thrombomodulin alfa

  • Protein C

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved